Middle East & Africa Gastric Cancer Diagnostic Procedure Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Healthcare Providers (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Types (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offerings [Instruments, Reagents & Consumables (Including Kits), and Services],  Disease Indication (Early Gastric Cancer and Advanced Gastric Cancer Types) and country

No. of Pages: 195    |    Report Code: BMIRE00028560    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Gastric Cancer Diagnostic Procedure Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in gastric cancer incidence
  • 5.1.2 Advancements in diagnostic technologies
  • 5.1.3 Rising demand for early cancer detection
5.2 Market Opportunities
  • 5.2.1 Rising focus on early detection and diagnostics for gastric cancer
  • 5.2.2 Growing availability of advanced diagnostic technologies
  • 5.2.3 Increasing adoption of non-invasive diagnostic procedures
5.3 Future Trends
  • 5.3.1 Increased use of non-invasive diagnostic technologies
  • 5.3.2 Advancements in biomarkers for gastric cancer detection
  • 5.3.3 Rising interest in personalized diagnostics for cancer treatment
5.4 Impact of Drivers and Restraints

6. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Regional Analysis

6.1 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Overview
6.2 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Revenue 2020-2028 (US$ Million)
6.3 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Forecast Analysis

7. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Analysis – by Healthcare Providers

7.1 Diagnostic Laboratories
  • 7.1.1 Overview
  • 7.1.2 Diagnostic Laboratories: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Hospitals
  • 7.2.1 Overview
  • 7.2.2 Hospitals: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Cancer Research Institutes
  • 7.3.1 Overview
  • 7.3.2 Cancer Research Institutes: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Oncology Specialty Clinics
  • 7.4.1 Overview
  • 7.4.2 Oncology Specialty Clinics: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Analysis – by Symptom Types

8.1 Symptomatic and Asymptomatic
  • 8.1.1 Overview
  • 8.1.2 Symptomatic and Asymptomatic: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Analysis – by Body Fluid

9.1 Blood
  • 9.1.1 Overview
  • 9.1.2 Symptomatic and Asymptomatic: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Urine
  • 9.2.1 Overview
  • 9.2.2 Symptomatic and Asymptomatic: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Saliva
  • 9.3.1 Overview
  • 9.3.2 Symptomatic and Asymptomatic: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Stomach Wash/Gastric Juice
  • 9.4.1 Overview
  • 9.4.2 Symptomatic and Asymptomatic: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Tissue
  • 9.5.1 Overview
  • 9.5.2 Symptomatic and Asymptomatic: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Middle East and Africa Analysis

10.1 Middle East and Africa
  • 10.1.1 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 South Africa: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 South Africa: Middle East & Africa Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
    • 10.1.1.1.2 South Africa: Middle East & Africa Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
    • 10.1.1.1.3 South Africa: Middle East & Africa Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
  • 10.1.1.2 Saudi Arabia: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Saudi Arabia: Middle East & Africa Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
    • 10.1.1.2.2 Saudi Arabia: Middle East & Africa Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
    • 10.1.1.2.3 Saudi Arabia: Middle East & Africa Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
  • 10.1.1.3 UAE: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 UAE: Middle East & Africa Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
    • 10.1.1.3.2 UAE: Middle East & Africa Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
    • 10.1.1.3.3 UAE: Middle East & Africa Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
  • 10.1.1.4 Rest of Middle East and Africa: Middle East & Africa Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Rest of Middle East and Africa: Middle East & Africa Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
    • 10.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
    • 10.1.1.4.3 Rest of Middle East and Africa: Middle East & Africa Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Bio-Rad Laboratories Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 bioMerieux SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Thermo Fisher Scientific Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Illumina Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Vela Diagnostics Holding Pte Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - M Market

  1. Bio-Rad Laboratories Inc
  2. F. Hoffmann-La Roche Ltd
  3. bioMerieux SA
  4. Thermo Fisher Scientific Inc
  5. Illumina Inc
  6. Vela Diagnostics Holding Pte Ltd
middle-east-and-africa-gastric-cancer-diagnostic-procedure-market